EDA YILDIZHAN

Dr. EDA YILDIZHAN


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2025
Verified
Journal Article
Open access
HBHüseyin Bilge
Hüseyin Bilge
EYEDA YILDIZHAN
EDA YILDIZHAN
Ischemia and reperfusion (I/R) can cause significant functional impairments in cells and tissues depending on the duration of ischemia. To date, many alternative treatments have been utilized to address this damage. We aimed to research the protective efficacy of taxifolin (Tax), a natural antioxidant, against liver I/R injury in terms of biochemical, histopathologic, and immunohistochemical parameters. The rats utilized in our study were randomly chosen and divided into four equal groups. Group 1 (n = 7), sham group received 1 mL saline orally; group 2 (n = 7), Tax group; Group 3 (n = 7), I/R group; group 4 (n = 7), Tax + I/R group as designated. The entire study was performed under general anesthesia with protection of animal welfare. Malondialdehyde (MDA) and interleukin-6 (IL-6) were analyzed from blood samples. Proapoptotic (B-cell lymphoma 2 [Bcl-2]-associated X protein [Bax]) and antiapoptotic (Bcl-2) amendments in cells were reviewed. MDA grades were lower in the Tax+I/R group compared to the I/R group. Likewise, IL-6 grades were lower in the Tax + I/R group, histologic examinations showed that Bax proteins were less expressed in the Tax + IR group, and Bcl-2 proteins were intensely expressed in the Tax group. Taxifolin applied before liver I/R demonstrated favorable effects on inflammation, oxidative stress, and proapoptotic changes.

1 January 2025 in Turkish Journal of Trauma and Emergency Surgery
Verified
Journal Article
Open access
EYEDA YILDIZHAN
EDA YILDIZHAN
Acute mesenteric artery ischemia is recognized as a significant cause of mortality and morbidity, with its incidence increasing with age. This study aims to investigate the efficacy of sesamin in mitigating the histological, immunological, and biochemical damage associated with superior mesenteric artery ischemia and reperfusion (SMA I/R) injury in the ileum. Twenty-eight Sprague-Dawley rats were randomly assigned into four equal groups. Group I (Control group): Received no treatment. Group II (SMA I/R group): Carboxymethylcellulose was mixed with distilled water and administered orally via gavage at a dose of 1 mL/kg/dose for three weeks. At the end of the third week, SMA ischemia was induced for 60 minutes followed by 120 minutes of reperfusion. Group III (Sesamin group): Received sesamin orally at a dose of 30 mg/kg via gavage for three weeks. Group IV (Sesamin + SMA I/R group): Received sesamin followed by SMA I/R. Serum malondialdehyde (MDA) levels were highest in the SMA I/R group, while lower levels were observed in the Sesamin + SMA I/R group (p<0.05). Similarly, total oxidant status (TOS) was significantly reduced in the Sesamin + SMA I/R group compared to the SMA I/R group (p<0.05). Consistent with these findings, Bax expression, a pro-apoptotic marker, was less intense in the Sesamin + SMA I/R group than in the SMA I/R group. Our findings indicate that the administration of sesamin prior to SMA I/R effectively reduces oxidative damage and prevents histological alterations, as demonstrated by histological, immunohistochemical, and biochemical parameters.

13 February 2026 in Life
Verified
Journal Article
Open access
PDF file
MKMahir Kuyumcu
Mahir Kuyumcu
EYEDA YILDIZHAN
EDA YILDIZHAN
Objectives: Cerebral ischemia/reperfusion (IR) injury is characterized by excessive oxidative stress and activation of apoptotic pathways, which play a central role in neuronal loss and poor neurological outcomes. Modulation of these mechanisms represents a clinically relevant strategy for neuroprotection. This study aimed to investigate the neuroprotective effects of dexmedetomidine (Dex) on oxidative stress, apoptotic signaling, and neuronal integrity in an experimental rat model of cerebral IR injury. Materials and Methods: Female Wistar rats were assigned to control, IR, and IR+Dex groups. Transient cerebral ischemia was induced for 45 min followed by 2 h of reperfusion. Oxidative stress was evaluated using serum antioxidant enzyme activities (superoxide dismutase [SOD], catalase [CAT], glutathione peroxidase [GSH-Px]), total oxidant and antioxidant status (TOS, TAS), and lipid peroxidation levels (malondialdehyde [MDA]). Apoptotic signaling was assessed by histopathological examination, transmission electron microscopy, and immunohistochemical analysis of B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax) and apoptotic peptidase activating factor-1 (APAF-1) expression, quantitatively evaluated using QuPath with statistical comparison between groups. Bioinformatic network analysis and molecular docking were performed to explore predicted interactions between Dex and apoptosis-related proteins. Results: Cerebral IR induced a marked oxidative imbalance, characterized by reduced antioxidant enzyme activities and increased lipid peroxidation. Dex treatment partially improved antioxidant capacity and reduced oxidative stress parameters. Histopathological and ultrastructural analyses demonstrated severe neuronal degeneration following IR, whereas Dex-treated rats exhibited attenuated neuronal damage and improved ultrastructural preservation. Immunohistochemical analysis showed increased Bax and APAF-1 expression and reduced Bcl-2 expression after IR; these alterations were significantly modulated toward control levels in the IR+Dex group. Bioinformatic analysis identified apoptosis-related pathways, including apoptosis, p53 signaling, and necroptosis, as significantly enriched, while molecular docking suggested stable predicted interactions between Dex and key apoptotic regulators. Conclusions: In this experimental rat cerebral IR model, Dex exerted partial but significant neuroprotective effects by attenuating oxidative stress, modulating apoptotic marker expression, and preserving neuronal morphology. These findings support the potential role of Dex as a neuroprotective agent in ischemia-related brain injury, warranting further translational investigation.

1 January 2026 in Journal of Veterinary Science
Verified
Journal Article
Open access
PDF file
HDHasan Mansur Durgun
Hasan Mansur Durgun
EYEDA YILDIZHAN
EDA YILDIZHAN
Durgun HM, et al. J Vet Sci. 2025 Dec;27:e3. https://doi.org/10.4142/jvs.25148

8 January 2026 in Gaceta Médica de México
Verified
Journal Article
Open access
PDF file
FUFeyzullah Uçmak
Feyzullah Uçmak
EYEDA YILDIZHAN
EDA YILDIZHAN
Antecedentes: Nuestro objetivo fue investigar la eficacia terapéutica del ácido alfa-lipoico (ALA) contra el estrés oxidativo inducido por el alcohol etílico (EA) y las vías apoptóticas en los riñones sobre la base de análisis bioquímicos, histopatológicos y apoptóticos. Materiales y métodos: Veintiocho ratas albinas Wistar fueron divididas aleatoriamente en cuatro grupos iguales. Grupo I (grupo Sham): 1 cc de solución salina al día; Grupo II (ALA): 100 mg/kg/dosis/día; Grupo III (grupo EA): 5 g/kg/día; Grupo IV (grupo EA + ALA): se administraron tanto ALA como EA por vía oral con sonda gástrica simultáneamente. Resultados: En el grupo EA, los niveles de malondialdehído y de estado oxidante total aumentaron, mientras que los niveles de superóxido dismutasa y catalasa disminuyeron significativamente (p = 0.002). Sin embargo, los niveles de oxidantes se estabilizaron significativamente con la administración de ALA. Además, las señales apoptóticas como Bax y APAF-1 aumentaron en el grupo EA, mientras que las señales Bcl-2 (antiapoptóticas) se expresaron ampliamente con la administración de ALA. Conclusiones: La coadministración de ALA con EA aumentó la expresión antiapoptótica y atenuó el daño histológico en los riñones. El ALA puede ser un potencial agente terapéutico contra la lesión por EA.